Insight Molecular Diagnostics Inc
(IMDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,826 | 39,257 | 8,034 | 10,821 | 10,294 |
| Marketable Securities | 518 | 606 | 428 | 830 | 728 |
| TOTAL | $37,064 | $40,993 | $8,642 | $11,896 | $11,404 |
| Non-Current Assets | |||||
| PPE Net | 413 | 486 | 614 | 722 | 615 |
| Other Non-Current Assets | 189 | 198 | 262 | 287 | 177 |
| TOTAL | $602 | $684 | $876 | $1,009 | $792 |
| Total Assets | $37,666 | $41,677 | $9,518 | $12,905 | $12,196 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 561 | 136 | 2,267 | 2,304 | 2,332 |
| Accrued Expenses | 2,486 | 1,957 | 2,109 | 1,044 | 1,043 |
| TOTAL | $4,061 | $3,197 | $5,561 | $4,619 | $4,485 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 159 | 347 | 531 | 713 |
| TOTAL | $100 | $293 | $534 | $763 | $865 |
| Total Liabilities | $4,161 | $3,490 | $6,095 | $5,382 | $5,350 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,599 | 2,599 | 2,599 | 2,033 | 2,033 |
| Common Shares | 114,071 | 113,370 | 74,742 | 74,343 | 70,695 |
| Retained earnings | -80,566 | -75,183 | -71,319 | -66,820 | -63,849 |
| TOTAL | $33,505 | $38,187 | $3,423 | $7,523 | $6,846 |
| Total Liabilities And Equity | $37,666 | $41,677 | $9,518 | $12,905 | $12,196 |